Indo Pureco Pratama Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Indo Pureco Pratama Tbk. trades at Rp14 (market cap 64.4B), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 6.7× Indo Pureco Pratama Tbk.'s market cap. Which is the better fit depends on your goals.
| IPPE | PRDL | |
|---|---|---|
Market Cap | 64.4B | 428.75B |
Volume | — | 13.83M |
Lot | — | 138.27K |
Turnover | — | 3.27B |
Average Price | — | 236.62 |
Value | — | 3.27B |
Indicative Equilibrium Price | — | 236 |
Indicative Equilibrium Volume | — | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indo Pureco Pratama Tbk ("the Company") was established based on Notarial Deed No. 839 dated March 20, 2019, by Joice Hapsari Fendrini, S.H., M.Kn., Notary in Subang. The Company started its commercial operations in March 2019. The Company has coconut flesh processing factory located at Balimbing, Sub-District Pagaden Barat, District Subang, West Java, Indonesia.
Read more on IPPE →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →